Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant.

Saved in:
Bibliographic Details
Title: Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant.
Authors: Ryan, Kathryn A.1 (AUTHOR) kathryn.ryan@ukhsa.gov.uk, Bewley, Kevin R.1 (AUTHOR), Watson, Robert J.1 (AUTHOR), Burton, Christopher1 (AUTHOR), Carnell, Oliver1 (AUTHOR), Cavell, Breeze E.1 (AUTHOR), Challis, Amy1 (AUTHOR), Coombes, Naomi S.1 (AUTHOR), Davies, Elizabeth R.1 (AUTHOR), Edun-Huges, Jack1 (AUTHOR), Emery, Kirsty1 (AUTHOR), Fell, Rachel1 (AUTHOR), Fotheringham, Susan A.1 (AUTHOR), Gooch, Karen E.1 (AUTHOR), Gowan, Kathryn1 (AUTHOR), Handley, Alastair1 (AUTHOR), Harris, Debbie J.1 (AUTHOR), Hesp, Richard1 (AUTHOR), Hunter, Laura1 (AUTHOR), Humphreys, Richard1 (AUTHOR)
Source: PLoS Pathogens. 4/4/2023, Vol. 18 Issue 4, p1-25. 25p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15537366
DOI:10.1371/journal.ppat.1011293